Oncology

Immunotherapy doesn’t need to be delayed due to antibiotic use in metastatic melanoma

Antibiotic use before immunotherapy does not lead to worse outcomes in metastatic melanoma, according to the results of a large cohort of patients with advanced melanoma. Overall survival (OS) and time-to-treatment discontinuation (TTD) were compared according to antibiotic use in the 3 months before the start of anti-PD-1 antibody as...